Spyre Therapeutics
SYRE
#2075
Rank
HK$69.58 B
Marketcap
HK$732.67
Share price
-4.26%
Change (1 day)
288.08%
Change (1 year)

EPS for Spyre Therapeutics (SYRE)

EPS in 2026 (TTM): -HK$21.96

According to Spyre Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$21.99. In 2025 the company made an earnings per share (EPS) of -HK$16.11 an increase over its 2024 EPS that were of -HK$29.19.

EPS history for Spyre Therapeutics from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$21.9636.32%
2025-HK$16.11-44.82%
2024-HK$29.19